Diagnostic work-up and outcome of cervical metastases from an unknown primary

Acta Oto-Laryngologica

Volumn 126, Issue 5, 2006, Pages 536-544

  Guntinas Lichius, Orlando ^a   Klussmann, J Peter ^a   Dinh, Stephen ^a   Dinh, Mai ^a   Schmidt, Matthias ^a   Semrau, Robert ^a   Mueller, Rolf Peter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Carcinoma of unknown primary; Chemotherapy; Head and neck cancer; Neck dissection; Positron emission tomography; Radiotherapy

Indexed keywords

ALCOHOL; CARBOPLATIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CERVICAL LYMPHADENOPATHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; TONSILLECTOMY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ENDOSCOPY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASMS, UNKNOWN PRIMARY; OTORHINOLARYNGOLOGIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33646513527     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480500417304     Document Type: Article

References (25)

1. Adams JR, O'Brien CJ. Unknown primary squamous cell carcinoma of the head and neck: a review of diagnosis, treatment and outcomes. Asian J Surg 2002;25:188-93.
2. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972;29:1446-9.
3. Issing W J, Taleban B, Tauber S. Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Otorhinolaryngol 2003;260:436-43.
4. Chepeha D, Koch W, Pitman K. Management of unknown primary tumor. Head Neck 2003;25:499-504.
5. Nieder C, Ang KK. Cervical lymph node metastases from occult squamous cell carcinoma. Curr Treat Options Oncol 2002;3:33-40.
6. Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 2004;30:153-64.
7. Johansen J, Eigtved A, Buchwald C, Theilgaard SA, Hansen HS. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope 2002;112:2009-14.
8. Nieder C, Gregoire V, Ang KK. Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 2001;50:727-33.
9. Iganej S, Kagan R, Anderson P, Rao A, Tome M, Wang R, et al. Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse. Head Neck 2002;24:236-46.
10. Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000;55:121-9.
11. Argiris A, Smith SM, Stenson K, Mittal BB, Pelzer HJ, Kies MS, et al. Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol 2003;14:1306-11.
12. TNM Classification of malignant tumours. New York: Wiley Press, 2002.
13. Jungehulsing M, Scheidhauer K, Damm M, Pietrzyk U, Eckel H, Schicha H, et al. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 2000;123:294-301.
14. Schmidt M, Schmalenbach M, Jungehulsing M, Theissen P, Dietlein M, Schroder U, et al. 18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis. Nuklearmedizin 2004;43:91-101.
15. Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002;128:751-8.
16. Hanasono MM, Kunda LD, Segall GM, Ku GH, Terris DJ. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999;109:880-5.
17. Haas I, Hoffmann TK, Engers R, Ganzer U. Diagnostic strategies in cervical carcinoma of an unknown primary (CUP). Eur Arch Otorhinolaryngol 2002;259:325-33.
18. Wong WL, Saunders M. The impact of FDG PET on the management of occult primary head and neck tumours. Clin Oncol (R Coll Radiol) 2003;15:461-6.
19. Lee DJ, Rostock RA, Harris A, Kashima H, Johns M. Clinical evaluation of patients with metastatic squamous carcinoma of the neck with occult primary tumor. South Med J 1986;79:979-83.
20. Rades D, Kuhnel G, Wildfang I, Borner AR, Schmoll HJ, Knapp W. Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management. Ann Oncol 2001;12:1605-9.
21. Jesse RH, Perez CA, Fletcher GH. Cervical lymph node metastasis: unknown primary cancer. Cancer 1973;31:854-9.
22. Coker DD, Casterline PF, Chambers RG, Jaques DA. Metastases to lymph nodes of the head and neck from an unknown primary site. Am J Surg 1977;134:517-22.
23. Altman E, Cadman E. An analysis of 1539 patients with cancer of unknown primary site. Cancer 1986;57:120-4.
24. Hainsworth JD, Greco FA. Treatment of patients with cancer of an unknown primary site. N Engl J Med 1993;329:257-63.
25. Koivunen P, Laranne J, Virtaniemi J, Back L, Makitie A, Pulkkinen J, et al. Cervical metastasis of unknown origin: a series of 72 patients. Acta Otolaryngol 2002;122:569-74.